Pharmaceuticals, Biotechnology and Life Sciences
First Time Disclosure of Clinical Candidates Presentation Scheduled for April 3, 2019 at 10:35am ET MALVERN, Pa.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/antibiotics?src=hash" target="_blank"gt;#antibioticslt;/agt;–VenatoRx…
Through April 5, Register for Complimentary Exhibit Hall & Keynote Pass to Boston Conference & Expo BOSTON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/BioIT19?src=hash" target="_blank"gt;#BioIT19lt;/agt;–In…
DUBLIN–(BUSINESS WIRE)–The “Genital Herpes – Pipeline Review, H1 2019” drug pipelines has been added to ResearchAndMarkets.com’s offering. Genital Herpes –…
NORTH BILLERICA, Mass.–(BUSINESS WIRE)–Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global…
Wins “Top Performer” in 12 categories NEWBURYPORT, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/APIs?src=hash" target="_blank"gt;#APIslt;/agt;–SEQENS North America (formerly PCI Synthesis, Inc.), a pharmaceutical manufacturer…
Entered into a merger agreement with C3J Therapeutics that is expected to result in an NYSE American-listed company focused on…
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmics Partnering 2014-2019: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering. Global Ophthalmics…
Data from a Phase 2 study in congenital hyperinsulinism (CHI) shared at ENDO 2019 and a budget impact model presented…
SAN DIEGO–(BUSINESS WIRE)–Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance,…
DUBLIN–(BUSINESS WIRE)–The “Global Sensory Organ Partnering 2014-2019: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering. Global…